Search hospitals > New Jersey > Camden
Md Anderson Cancer Center At Cooper
Claim this profileCamden, New Jersey 08103
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Adenocarcinoma
58 reported clinical trials
9 medical researchers
Summary
Md Anderson Cancer Center At Cooper is a medical facility located in Camden, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Ovarian Cancer, Adenocarcinoma and other specialties. Md Anderson Cancer Center At Cooper is involved with conducting 58 clinical trials across 102 conditions. There are 9 research doctors associated with this hospital, such as David P. Warshal, Farhad Ravandi-Kashani, Tulin Budak-Alpdogan, and Gregory Kubicek, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
David P. WarshalCooper Hospital University Medical Center2 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
13 reported clinical trials
30 drugs studied
Farhad Ravandi-KashaniM D Anderson Cancer Center3 years of reported clinical research
Studies Leukemia
Studies Acute Myeloid Leukemia
11 reported clinical trials
24 drugs studied
Tulin Budak-AlpdoganCooper Hospital University Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Plasma Cell Neoplasms
5 reported clinical trials
16 drugs studied
Gregory Kubicek, MDCooper Hospital University Medical Center3 years of reported clinical research
Studies Cancer
Studies Head and Neck Cancers
3 reported clinical trials
6 drugs studied
Clinical Trials running at Md Anderson Cancer Center At Cooper
Breast Cancer
Melanoma
Follicular Lymphoma
Prostate Cancer
Acute Promyelocytic Leukemia
Colorectal Cancer
Lobular Carcinoma in Situ
Lobular Carcinoma
Breast Lobular Carcinoma in Situ
Cancer
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Inavolisib + Fulvestrant vs Alpelisib + Fulvestrant
for Breast Cancer
This trial is testing two drug combinations to find out which one is better for treating a specific type of advanced breast cancer that hasn't responded to previous treatments. The drugs work by stopping cancer cells from growing and spreading.
Recruiting2 awards Phase 310 criteria
Tamoxifen vs. TamGel
for Breast Cancer Risk Reduction
This trial is testing two forms of tamoxifen—a low-dose pill and a skin-applied gel. It targets women with conditions that put them at higher risk for breast cancer. The medication works by blocking estrogen, which can help stop cancer cells from growing. Tamoxifen is a well-established treatment for breast cancer, known for its ability to block estrogen receptors and reduce breast cancer incidence.
Recruiting2 awards Phase 210 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Md Anderson Cancer Center At Cooper?
Md Anderson Cancer Center At Cooper is a medical facility located in Camden, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Ovarian Cancer, Adenocarcinoma and other specialties. Md Anderson Cancer Center At Cooper is involved with conducting 58 clinical trials across 102 conditions. There are 9 research doctors associated with this hospital, such as David P. Warshal, Farhad Ravandi-Kashani, Tulin Budak-Alpdogan, and Gregory Kubicek, MD.